Alpine Woods Capital Doubles Down on Amgen

Alpine Woods Capital Investors LLC significantly increased its stake in Amgen Inc. (NASDAQ: AMGN), acquiring an additional 4,003 shares during the first quarter.

The company disclosed this information through a recent filing with the Securities & Exchange Commission (SEC).

This new purchase represents a 21% boost to Alpine Woods Capital Investors LLC's position in Amgen, which now totals 23,064 shares. The value of these shares is approximately $8,115,000.